バイオ医薬品におけるグローバルのエンドーツーエンドCDMOサービスのご紹介　（2021年11月）

現在伸び続けているバイオ医薬品のニーズが高まっており、CDMOをパートナーとしてお使いいただくケースが増えています。パセオンは医薬品の開発から治験薬製造、そして商業生産のみならず、多岐にわたる治験関連サポート（治験サプライチェーン）も展開しております。

現在グローバルCDMOがどのようなサービスを展開しお客様のパートナーとして、迅速に開発から上市までサポートしているのかをお話いたします。パセオン株式会社、アジアパシフィック事業開発部門長の谷元浩二が日本語でわかりやすくお話いたします。

関連する施設紹介

Pretoria, ZA

Pretoria, ZA

Mexico City, MX

Mexico City, MX

Vacaville, CA

Vacaville, CA

Rockville, MD

Rockville, MD

Frederick, MD

Frederick, MD

Franklin, MA

Franklin, MA

Indianapolis, IN

Indianapolis, IN

Bohemia, NY

Bohemia, NY

São Paulo, Brazil

São Paulo, BR

Santiago, Chile

Santiago, CL

Lima, Peru

Lima, PE

Bogotá, Colombia

Bogotá, CO

Weil am Rhein

Weil am Rhein, DE

Bishops Stortford, UK

Bishops Stortford, UK

Mount Prospect, Illinois

Mount Prospect, IL

Allentown, PA

Allentown, PA

Buenos Aires, Argentina

Buenos Aires, AR

Stevenage, UK

Stevenage, UK

Moscow, Russia

Moscow, RU

Horsham, UK

Horsham, UK

Basel, Switzerland

Basel, CH

Suzhou, China

Suzhou, CN (Free Trade Zone)

Tokyo, JP

Tokyo, JP

Singapore

Singapore

Incheon, Korea

Beijing, CN

Beijing, CN

Ahmedabad, IN (Domestic Tariff Area)

Ahmedabad, IN (Domestic Tariff Area)

Ahmedabad, IN (SEZ)

Ahmedabad, IN (Special Economic Zone)

Brisbane, AU

Brisbane, AU

Ferentino, IT

Ferentino, IT

Greenville, NC

Greenville, NC

Groningen, NL

Groningen, NL

Monza, IT

Monza, IT

Princeton, NJ

Princeton, NJ

St. Louis, MO

St. Louis, MO

Swindon, UK

Swindon, UK

関連する各種資料

Essential up-front planning for your clinical trial

Sterile formulation strategies to shorten timelines for first-in-human studies

Steriles Drug Development & Manufacturing: Flexibility and Optimization

Orphan Drugs: Balancing Financial Incentives & Complex Challenges

mysupply Platform: An End-to-End Digital Supply Chain Platform

Growing Your Biopharma: Ten Questions You're Likely to Face From Investors—And How to Respond to Them

A Tale of Two CDMOs: Which Choice Will Your Biopharma Make?

Impact of a Pandemic Outbreak on Vaccine Development Approach

Vaccine Development: Strategic Approach & Response During Pandemics

Analytical Considerations For Biopharmaceuticals During Commercialization

Benefits of 5KL Bioreactor When Outsourcing Late-phase Biologics Drug Substance Manufacturing

Practical Implementation of Innovative and Scalable Technologies to Accelerate Biologics Development and Commercialization: A CDMO Perspective

Shortening The Timeline To First In Human (FIH) Clinical Dosage Form For Oral/Injectable Delivery

Does Your Clinical Trial Design Satisfy the Needs of your Patients

Leveraging Infrastructure Investments and Innovation to Accelerate Biologics Development

Total Transportation Management for the Life Science Industry Fact Sheet

Accelerating Cell Culture Development through Practical Application of Innovation Technologies

Leveraging Innovative Technologies, Best Practices and Strategies to Accelerate Biologics Development and Commercialization

Factoring the "What Ifs" into Supply Forecasting

Transportation Solutions for Cell and Gene Therapy Supply Chains

Direct-to-Patient Pharmacy Services Overview

Depot-to-Patient Service Infographic

Total Transportation Management Saves Company $10.2M

Ancillary Supplies: Clinical Trial "Must-Haves" that Require Early Planning

Clinical Trial Packaging: Smart Choices can Trim Timelines

Clinical Trial Packaging Solutions: Balancing Cost, Time and Quality

The Challenge of Keeping Cool: End-to-End Temperature Management for the Clinical Chain Supply

Managing Temperature Excursions

Reasons for Building an Approved Phrase Library

Taking a Strategic Approach to Comparator Drug Sourcing

What You Need to Know About Process Characterization and Validation For Biologic Processes

Choosing the Right CDMO for Late Phase Clinical Trials

Biopharma Capabilities Overview

Pharma Services Overview Brochure

Getting to First-in-Human Clinical Trials: A Make-or-Break Milestone for Small Biopharmas

Biologics Overview: Flexible Biomanufacturing Solutions

Top Five Risks Facing Your Small Biopharma Clients Today

Multiplexing: Managing Risk with Proven, Single-Use Solutions